References
- Driessen EJ, Bootsma GP, Hendriks LE, et al. Stage III Non- Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice. Radiother Oncol 2016;121:26-31. https://doi.org/10.1016/j.radonc.2016.07.025
- Sacher AG, Le LW, Leighl NB, Coate LE. Elderly patients with advanced NSCLC in phase III clinical trials: are the elderly excluded from practice-changing trials in advanced NSCLC? J Thorac Oncol 2013;8:366-8. https://doi.org/10.1097/JTO.0b013e31827e2145
- Atagi S, Mizusawa J, Ishikura S, et al. Randomized trial of thoracic radiotherapy with or without concurrent daily lowdose carboplatin in elderly patients with locally advanced non-small cell lung cancer (NSCLC): long-term follow-up of Japan Clinical Oncology Group (JCOG) study JCOG0301. J Clin Oncol 2017:35(15_Suppl):8532. https://doi.org/10.1200/JCO.2017.35.15_suppl.8532
- Atagi S, Kawahara M, Yokoyama A, et al. Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). Lancet Oncol 2012;13:671-8. https://doi.org/10.1016/S1470-2045(12)70139-0
- Dawe DE, Christiansen D, Swaminath A, et al. Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: a systematic review and meta-analysis. Lung Cancer 2016;99:180-5. https://doi.org/10.1016/j.lungcan.2016.07.016
- Miller ED, Fisher JL, Haglund KE, et al. The addition of chemotherapy to radiation therapy improves survival in elderly patients with stage III non-small cell lung cancer. J Thorac Oncol 2018;13:426-35. https://doi.org/10.1016/j.jtho.2017.11.135
- Driessen EJ, Schulkes KJ, Dingemans AC, van Loon JG, Hamaker ME, Aarts MJ, et al. Patterns of treatment and survival among older patients with stage III non-small cell lung cancer. Lung Cancer 2018;116:55-61. https://doi.org/10.1016/j.lungcan.2017.12.013
- Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004;57):1288-94.
- Ezer N, Smith CB, Galsky MD, et al. Cisplatin vs. carboplatinbased chemoradiotherapy in patients >65 years of age with stage III non-small cell lung cancer. Radiother Oncol 2014;112:272-8. https://doi.org/10.1016/j.radonc.2014.07.014
- Harris JP, Murphy JD, Hanlon AL, Le QT, Loo BW Jr, Diehn M. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2014;88:872-84. https://doi.org/10.1016/j.ijrobp.2013.12.010
- Auperin A, Le Pechoux C, Rolland E, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010;28:2181-90. https://doi.org/10.1200/JCO.2009.26.2543
- Fournel P, Vergnenegre A, Robinet G, et al. Induction or consolidation chemotherapy for unresectable stage III nonsmall-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC-IFCT 02-01. Eur J Cancer 2016;52:181-7. https://doi.org/10.1016/j.ejca.2015.10.072
- Holgersson G, Sandelin M, Hoye E, et al. The value of induction chemotherapy for survival in patients with non-small cell lung cancer treated with radiotherapy. Anticancer Res 2012;32:1339-46.
- Ardizzzoni A, Boni L, Scolaro T, et al. Induction chemotherapy followed by thoracic irradiation with or without concurrent chemotherapy in locally advanced inoperable NSCLC: a randomized phase III trial. J Clin Oncol 2008:26(15_ Suppl):7520. https://doi.org/10.1200/jco.2008.26.15_suppl.7520
- Huang EH, Liao Z, Cox JD, et al. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone. Int J Radiat Oncol Biol Phys 2007;68:779-85. https://doi.org/10.1016/j.ijrobp.2007.01.002
- Luo H, Yu X, Liang N, Xie J, Deng G, Liu Q, Zhang J, Zhang J, Ge H. The effect of induction chemotherapy in patients with locally advanced nonsmall cell lung cancer who received chemoradiotherapy: a systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e6165. https://doi.org/10.1097/md.0000000000006165
- Soto-Perez-de-Celis E, Li D, Yuan Y, Lau YM, Hurria A. Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer. Lancet Oncol 2018;19:e305-e316. https://doi.org/10.1016/S1470-2045(18)30348-6
Cited by
- Nutritional Support in Lung Cancer Patients: The State of the Art vol.22, pp.4, 2021, https://doi.org/10.1016/j.cllc.2020.10.008